Three Years of Continuous BCI Speech Sets a New Bar for Neural Interface Durability
Casey Harrell's 3-year ALS speech BCI record shifts the competitive question from 'does it work?' to 'can it last?'
8. Three Years of Continuous BCI Speech Sets a New Bar for Neural Interface Durability
Casey Harrell, a man living with ALS-related paralysis, has now used a speech-restoration brain-computer interface for nearly three years, logging thousands of hours of active use since his first decoded sentences in 2023. The implant, a set of cortical electrodes, translates neural signals into synthesized speech in real time. No prior published deployment of a speech-restoration BCI comes close to this duration of continuous real-world use, making Harrell what the research team calls "the first power user" of the technology.
That framing matters strategically. The BCI field has spent the last decade proving feasibility: Synchron, Neuralink, and BrainGate have each demonstrated that paralyzed patients can control cursors, type, or generate speech in controlled settings. Harrell's three-year record shifts the competitive question. Durability and daily usability are now the metrics that separate research milestones from clinical products. Neuralink's N1 implant, currently in its PRIME study with a small patient cohort, has not yet published comparable longitudinal data. Synchron's Stentrode avoids open-brain surgery but trades off signal resolution. The team behind Harrell's implant now holds the most credible long-term performance claim in the speech-BCI category.
The broader pattern here is the move from proof-of-concept to proof-of-endurance across the neural interface sector. FDA Breakthrough Device designations are accumulating, but reimbursement and broad clinical adoption hinge on multi-year stability data. Harrell's case gives regulators and payers a concrete reference point. Watch for Neuralink and Synchron to accelerate publication of their own longitudinal outcomes in response, and for the research team here to use this record as the anchor of a formal regulatory submission.
Source: This man with ALS is "the first power user" of a brain implant that lets him speak